Does LATANOPROST\NETARSUDIL Cause Product packaging quantity issue? 13 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 13 reports of Product packaging quantity issue have been filed in association with LATANOPROST\NETARSUDIL. This represents 2.1% of all adverse event reports for LATANOPROST\NETARSUDIL.
13
Reports of Product packaging quantity issue with LATANOPROST\NETARSUDIL
2.1%
of all LATANOPROST\NETARSUDIL reports
0
Deaths
0
Hospitalizations
How Dangerous Is Product packaging quantity issue From LATANOPROST\NETARSUDIL?
Of the 13 reports.
Is Product packaging quantity issue Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LATANOPROST\NETARSUDIL. However, 13 reports have been filed with the FAERS database.
What Other Side Effects Does LATANOPROST\NETARSUDIL Cause?
Conjunctival hyperaemia (98)
Ocular hyperaemia (96)
Eye irritation (76)
Vision blurred (76)
Lacrimation increased (53)
Eye pruritus (50)
Eye pain (37)
Intraocular pressure increased (36)
Product dose omission issue (31)
Conjunctival haemorrhage (28)
What Other Drugs Cause Product packaging quantity issue?
LEUPROLIDE (523)
ALBUTEROL (431)
BUDESONIDE\FORMOTEROL (301)
FENTANYL (286)
BUPRENORPHINE (225)
CYCLOSPORINE (206)
ESTRADIOL (201)
BIMATOPROST (177)
RIVAROXABAN (174)
EXENATIDE (154)
Which LATANOPROST\NETARSUDIL Alternatives Have Lower Product packaging quantity issue Risk?
LATANOPROST\NETARSUDIL vs LATANOPROST\TIMOLOL
LATANOPROST\NETARSUDIL vs LATISSE
LATANOPROST\NETARSUDIL vs LATUDA
LATANOPROST\NETARSUDIL vs LAZERTINIB
LATANOPROST\NETARSUDIL vs LEBRIKIZUMAB-LBKZ